Methylpiperidino pyrazole
Names
[ CAS No. ]:
289726-02-9
[ Name ]:
Methylpiperidino pyrazole
[Synonym ]:
4,4'-(4-Methyl-5-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-1H-pyrazole-1,3-diyl)diphenol dihydrochloride
4,4'-(4-Methyl-5-{4-[2-(1-piperidinyl)ethoxy]phenyl}-1H-pyrazole-1,3-diyl)diphenol dihydrochloride
MPP dihydrochloride hydrate
Phenol, 4,4'-[4-methyl-5-[4-[2-(1-piperidinyl)ethoxy]phenyl]-1H-pyrazole-1,3-diyl]bis-, hydrochloride (1:2)
MPP dihydrochloride
Methyl-piperidino-pyrazole hydrate
Biological Activity
[Description]:
MPP is a highly selective estrogen receptor alpha (ERα) antagonist. MPP reduces the ratio of p-ERα/ERα[1].https://www.ncbi.nlm.nih.gov/pubmed/29799481Labouesse MA, et al. Effects of selective estrogen receptor alpha and beta modulators on prepulse inhibition in male mice. Psychopharmacology (Berl). 2015 Aug;232(16):2981-94.https://www.ncbi.nlm.nih.gov/pubmed/25893642
[In Vitro]
MPP (1, 5, 10, 25, 50 and 100 µM; 24 h) decreases cell viability with an IC50 value of 20.01 µM in RL95-2 cells[1]. MPP dihydrochloride shows antiproliferative activity at a concentration of 10 μM in RL95-2 cells[1]. MPP dihydrochloride (20 µM; 24 h) reduces the phosphorylation of ERα, while it does not alter the phosphorylation of Akt. MPP dihydrochloride reduces the ratio of p-ERα/ERα[1]. Cell Viability Assay[1] Cell Line: RL95-2 endometrium cancer cells Concentration: 1, 5, 10, 25, 50 and 100 µM Incubation Time: 24 hours Result: The treatment with 25 µM, 50 µM and 100 µM for 24 h decreased cell viability significantly. However, cell viability was not significantly changed by MPP dihydrochloride at concentration below 25 µM. Cell Proliferation Assay[1] Cell Line: RL95-2 cell Concentration: 10, 15, 20 and 25 µM Incubation Time: 72 hours Result: Showed antiproliferative activity at a concentration of 10 μM. Western Blot Analysis[1] Cell Line: RL95-2 cell line Concentration: 20 µM Incubation Time: 24 hours Result: Reduced the phosphorylation of ERα, while it did not alter the phosphorylation of Akt. Reduced the ratio of p-ERα/ERα compared to the control group.
[In Vivo]
MPP (Low dose 20 μg/kg body weight or high dose 200 μg/kg body weight) leads to a dose-dependent attenuation of percent prepulse inhibition (PPI)[2]. Animal Model: Male C57BL/6N mice at the age of 9-10 weeks[2] Dosage: Low dose (20 μg/kg body weight) or high dose (200 μg/kg body weight) Administration: Administered subcutaneously (s.c.) injected; injection volume of 5 mL/kg; 60 min before PPI testing Result: Led to a dose-dependent attenuation of percent PPI. Pretreatment with 200 μg/kg reduced the mean percent PPI scores by ~30%.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C29H31N3O3
[ Molecular Weight ]:
469.57
[ Exact Mass ]:
541.189880
[ PSA ]:
70.75000
[ LogP ]:
7.33250
Safety Information
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.